BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16722463)

  • 1. [Impairment of the ubiquitin-proteasome system and neurodegeneration].
    Tanaka K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Apr; 26(2):67-73. PubMed ID: 16722463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin, proteasome and parkin.
    Tanaka K; Suzuki T; Hattori N; Mizuno Y
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):235-47. PubMed ID: 15571819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin is linked to the ubiquitin pathway.
    Tanaka K; Suzuki T; Chiba T; Shimura H; Hattori N; Mizuno Y
    J Mol Med (Berl); 2001 Sep; 79(9):482-94. PubMed ID: 11692161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin-associated Parkinson's disease.
    von Coelln R; Dawson VL; Dawson TM
    Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.
    Schlossmacher MG; Shimura H
    Methods Mol Biol; 2005; 301():351-69. PubMed ID: 15917645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic mechanisms of parkin in Parkinson's disease.
    Hattori N; Mizuno Y
    Lancet; 2004 Aug 21-27; 364(9435):722-4. PubMed ID: 15325839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autosomal recessive juvenile parkinsonism: its pathogenesis is involved in the ubiquitin-proteasome pathway].
    Hattori N; Shimura H; Kubo S; Suzuki T; Tanaka K; Mizuno Y
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1293-6. PubMed ID: 11464483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parkin gene and its function; a key to understand nigral degeneration].
    Hattori N; Mizuno Y
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1259-61. PubMed ID: 10791092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin genetics: one model for Parkinson's disease.
    Mata IF; Lockhart PJ; Farrer MJ
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R127-33. PubMed ID: 14976155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's Disease.
    Suresh K; Mattern M; Goldberg MS; Butt TR
    Neuromolecular Med; 2023 Sep; 25(3):313-329. PubMed ID: 36739586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin directly modulates 26S proteasome activity.
    Um JW; Im E; Lee HJ; Min B; Yoo L; Yoo J; Lübbert H; Stichel-Gunkel C; Cho HS; Yoon JB; Chung KC
    J Neurosci; 2010 Sep; 30(35):11805-14. PubMed ID: 20810900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.
    Shimura H; Hattori N; Kubo Si; Mizuno Y; Asakawa S; Minoshima S; Shimizu N; Iwai K; Chiba T; Tanaka K; Suzuki T
    Nat Genet; 2000 Jul; 25(3):302-5. PubMed ID: 10888878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.